Artivion (AORT) Free Cash Flow Growth (3y) (2013 - 2026)
Artivion (AORT) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -0.27% |
| 10 | Artivion | 1.26 Bn | 1.21 Bn | 75.45 Mn | 8.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.69% |
| Dec 31, 2025 | -25.63% |
| Sep 30, 2025 | 151.70% |
| Jun 30, 2025 | 46.70% |
| Mar 31, 2025 | -93.62% |
| Dec 31, 2024 | 88.59% |
| Sep 30, 2024 | 48.34% |
| Jun 30, 2024 | 46.87% |
| Mar 31, 2024 | -26.09% |
| Dec 31, 2023 | 35.37% |
| Sep 30, 2023 | -6.33% |
| Jun 30, 2023 | 44.59% |
| Mar 31, 2023 | -357.44% |
| Dec 31, 2022 | -30.83% |
| Sep 30, 2022 | -53.46% |
| Jun 30, 2022 | -93.23% |
| Mar 31, 2022 | -341.35% |
| Dec 31, 2021 | -30.17% |
| Sep 30, 2021 | -41.55% |
| Jun 30, 2021 | -87.54% |